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Background: The vascular complications of outpatients with diabetes at ordinary hospitals vary. Ischemic heart
disease is barely predictable after treatment using previously reported therapeutic indices. We developed a simple
and noninvasive screening method to evaluate the possibility of ischemic heart disease in patients with diabetes.
Methods: Five years of clinical data from 337 outpatients (196 males and 141 females) with diabetes were analyzed.
Twenty-three males and 14 females had ischemic heart disease. We examined the possibility of predicting ischemic
heart disease after analyzing this population. The analyzed laboratory data included the following: minimum value of
right or left ankle–brachial indices (ABI), maximum value of right or left pulse wave velocities (PWV), aortic calcification
diagnosed on plain chest radiographs, plaque score (PS), maximum value of intima media thickness at the cervical
artery (IMT), electrocardiographic (ECG) ischemic changes (including ST-T changes or abnormal Q waves, which were
re-examined by a cardiologist), HbA1c, low-density lipoprotein cholesterol (LDL-C), uric acid (UA), urine albumin, age,
sex, disease duration, and body mass index. All data were subjected to multivariate logistic regression analyses.
Results: The presence of ECG ischemic changes, aortic calcification, minimum ABI, maximum IMT, LDL-C, and UA were
evaluated in multivariate logistic regression analysis with the onset of ischemic heart disease. The receiver operating
characteristic curve indicated an area under the curve of 0.879 (0.820 - 0.938; P = 0.00).
Conclusions: Ischemic heart disease could be predicted in patients with diabetes using a combination of results from
conventional physical and laboratory tests.Introduction
The evaluation of diabetic microangiopathies is well estab-
lished, and there are many ways to predict prognoses. Al-
though ischemic heart disease is lethal, the prognosis of
diabetic macroangiopathy cannot be diagnosed without in-
vasive procedures and computed tomography of the cor-
onary arteries.
Contrast material may induce acute renal failure when a
patient with diabetes is subjected to a radiological proced-
ure [1]. Moreover, a large population cannot be surveyed
with invasive tests because of the high cost. Therefore, a
prescreening test is mandatory before invasive procedures.
Useful procedures to predict ischemic risk have been re-
ported, such as the Framingham score, maximum intima
media thickness (IMT), ankle–brachial index (ABI), pulse* Correspondence: kajimoto@ommc-hp.jp
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unless otherwise stated.wave velocity (PWV), aortic calcification, and coronary ar-
tery calcium score [2-6].
However, the Framingham score does not reflect the on-
going state of atherosclerosis; it only evaluates future risks
caused by the metabolic condition attributed to a patient’s
lifestyle. The Framingham study may have underestimated
risk because it analyzed a large untreated population and,
consequently, could not evaluate outpatients with diabetes
and atherosclerosis. Generally, atherosclerosis has already
progressed in patients with glucose intolerance, and ath-
erosclerotic risk increases continuously after a diagnosis of
diabetes is made. Our population with diabetes was differ-
ent from that in the Framingham study [7,8]. Interestingly,
situations like this in diabetes mellitus have also been
found in chronic inflammatory rheumatic diseases such as
rheumatoid arthritis; a disease associated with accelerated
atherosclerosis with an increased risk of cardiovascular
death similar to diabetes mellitus [9]. In rheumatoid arth-
ritis, risk charts such as the Systematic COronary Risk
Evaluation (SCORE) used to establish 10-year risk of fatalal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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cular risk of these patients. In this regard, recent studies
have disclosed that patients with rheumatoid arthritis in-
cluded in the category of moderate risk according to the
SCORE risk chart have severe subclinical atherosclerosis
when carotid ultrasound is performed [10,11].
An evaluation of complication risk is practically difficult
because each outpatient is at a different stage of athero-
sclerosis during prognosis prediction. Moreover, predict-
ing cardiovascular risk from the Framingham score is
superfluous after treatment initiation.
Some studies have indicated that prognosis can be pre-
dicted by a single physical test such as measurement of
maximum IMT, ABI, or PWV. Other studies have sug-
gested that several laboratory tests can be combined and
scored to predict the atherosclerotic prognosis in patients
with diabetes.
Most of these studies analyzed a general population
using radiation equipment during a mass screening; how-
ever, these tests have irradiation-associated side effects
[12-14]. To overcome these problems, we studied an alter-
native method to combine several conventional tests and
patient data to score the risk of ischemic heart diseases in
patients with diabetes.
Methods
A total of 337 patients (196 males and 141 females) with
diabetes who visited our hospital between June 2008 and
June 2013 were retrospectively analyzed. We performed
physiological and imaging tests, including ABI measure-
ment, plain chest radiography, cervical ultrasonography,
annual electrocardiography, and blood tests. The latter-
most included uric acid (UA) and the measurement of
HbA1c, low-density lipoprotein cholesterol (LDL-C), and
urinary albumin.
These tests were selected because they relate to ischemic
heart disease and are used in routine clinical practice [15].
Our study was approved by the ethics committee of
our hospital. The patients’ clinical data were retrieved
from our hospital host computer.
We selected the latest ABI measurement, plain chest
radiograph, and cervical ultrasonography data that reflected
the progression of atherosclerosis. Abnormal ECGs were
re-examined by a cardiologist. We regarded the test as posi-
tive if ST-T changes or abnormal Q waves appeared once in
5 years. However, in patients who developed ischemic heart
disease in the past five years, we did not consider both the
ECG findings after treatment and ECG findings in cardiac
attack, but the ECG before the ischemic attack.
Medications such as hypoglycemic agents, statins, and
anti-hyperuricemic drugs were not considered. We used
the mean values of the laboratory data for 5 years because
short-term variations in each value can mask the long-
term metabolic state.Disease duration and body mass index (BMI) data from
2008 were selected for analysis. Carotid artery ultrasonog-
raphy and ABI included two values for the left and right
sides. The larger value that reflected the progression of
atherosclerosis was selected for analysis.
A smaller ABI value indicates a higher risk of ischemic
heart disease. We selected either the right or left ABI
that was smaller (minimum ABI value). We also chose
each test that is conventionally used and has some rela-
tionship with atherosclerosis [2-6]. Among the 337 pa-
tients (196 males and 141 females) with diabetes, 37
patients (23 males and 14 females) suffered an ischemic
heart disease within 5 years. Diagnosis of ischemic heart
disease defined as the endpoint was performed with car-
diac catheterization. Ischemic heart disease included 27
stable angina, 3 unstable angina, 4 non ST elevation
myocardial infarction (NSTEMI), and 3 ST elevation
myocardial infarction (STEMI).
Results
The clinical characteristics of the 337 patients are shown in
Table 1. Their mean age was 68.3 ± 10.2 years and their
mean BMI was 24.1 ± 4.1 kg/m2. The mean disease dur-
ation was 14.2 ± 9.7 years. Seventy-eight patients exhibited
ST-T changes and abnormal Q waves on their electrocar-
diogram (ECG), while 135 exhibited aortic calcification on
a plain chest radiograph. The minimum ABI value was
1.08 ± 0.13, maximum PWV was 1830 ± 438 cm/s, max-
imum IMT was 1.91 ± 1.17 mm, plaque score was 5.12 ±
6.26, HbA1c level was 7.36 ± 1.52% (57.0 ± 16.6 mmol/
mol), LDL-C level was 106.1 ± 28.2 mg/dl, HDL-C level
was 60.8 ± 17.6 mg/dl, uric acid level was 5.32 ± 1.35 mg/dl,
and urinary albumin level was 157 ± 400 mg/g · Cr). The
plaque score was computed by summing the maximum
thickness of the intima-media complex measured in milli-
meters on the near and far walls at each of four divisions of
both sides of the carotid arteries on the B-mode image [16].
As objective variables are nominally scaled, multivari-
ate logistic analysis was performed with a two-sided test
(P < 0.05). Statistical analyses were performed with SPSS
ver. 20 and SPSS regression ver. 20 (SPSS Inc., Chicago,
IL, USA), except for multicollinearity analysis, which
was performed using EZR (Saitama Medical Center, Jichi
Medical University), a graphical user interface for R soft-
ware (The R Foundation for Statistical Computing) [17].
We used an arbitrary number of ischemic artery sten-
osis as the independent variable. The presence or ab-
sence of an ischemic heart disease was represented as
the number “1” or “0”, respectively. The dependent vari-
ables of gender, ECG findings, and plain chest radio-
graph findings were also marked in the following way:
gender, male (0), female (1); ST-T change or abnormal
Q wave on ECG, positive (1), negative (0); and aortic
calcification, positive (1), negative (0).
Table 1 Patient characteristics
Male Female Total
Mean ± SD Patients Mean ± SD Patients Mean ± SD Patients
Age, years 67.9 ± 10.2 196 69.0 ± 10.2 141 68.3 ± 10.2 337
BMI, kg/m2 24.4 ± 3.9 196 23.8 ± 4.3 141 24.1 ± 4.1 337
Duration, years 14.1 ± 9.7 196 14.3 ± 9.6 141 14.2 ± 9.7 337
ST-T change or abnormal
Q in ECG
Positive in 51 Positive in 27 Positive in 78
Aortic calcification in
plain chest radiographs
Positive in 79 Positive in 56 Positive in 135
Minimum value of ABI 1.09 ± 0.14 196 1.08 ± 0.12 141 1.08 ± 0.13 337
Maximum value of PWV 1820 ± 419 196 1840 ± 438 141 1830 ± 438 337
Maximum IMT, mm 2.09 ± 1.14 196 1.66 ± 1.17 141 1.91 ± 1.17 337
Plaque score 5.56 ± 6.47 196 4.51 ± 5.93 141 5.12 ± 6.26 337
HbA1c, % (mmol/mol) 7.25 ± 1.48 (56.0 ± 16.2) 196 7.50 ± 1.58 (58.0 ± 17.3) 141 7.36 ± 1.52 (57.0 ± 16.6) 337
LDL-C, mg/dl 103 ± 26.1 196 111 ± 29.8 141 106.1 ± 28.2 337
HDL-C, mg/dl 55.8 ± 15.8 196 67.9 ± 17.6 141 60.8 ± 17.6 337
uric acid, mg/dl 5.76 ± 1.33 196 4.70 ± 1.11 141 5.32 ± 1.35 337
urinary albumin, mg/g·Cr 173 ± 406 196 135 ± 392 141 157 ± 400 337
Minimum value of ABI (right or left ankle–brachial index), maximum value of PWV (right or left pulse wave velocity).
The plaque score was computed by summing the maximum thickness of the intima-media complex measured in millimeters on the near and far walls at each of
four divisions of both sides of the carotid arteries on the B-mode image.
Kajimoto et al. Diabetology & Metabolic Syndrome 2014, 6:51 Page 3 of 6
http://www.dmsjournal.com/content/6/1/51There were 14 independent variables; therefore, we first
surveyed for a significant relationship between ischemic
heart disease and other factors. Univariate logistic regres-
sion analysis was performed between other independent
variables and ischemic heart disease, which was defined as
a dependent variable.
The unilogistic regression analysis revealed a significant
correlation between ischemic heart disease and ECG
changes [odds ratio (OR), 7.32; P < 0.01], minimum ABI
(OR, 0.0478; P = 0.004), maximum PWV (OR, 1.00; P =
0.01), maximum IMT (OR, 1.50; P = 0.003), plaque score
(OR, 1.07; P = 0.004), LDL-C (OR, 0.963; P < 0.001), and
UA (OR, 1.47; P = 0.003).
The OR for maximum PWV was 1.00 among significant
dependent variables. We omitted this data in subsequent
multivariate regression analysis. The OR for LDL-C was
0.960, but this variable did not have a positive relationship
with ischemic heart disease. This independent factor was
an average value for 5 years. The observation that patients
were strictly controlled with statins after an ischemic heart
disease or diagnosis of severe atherosclerosis to prevent is-
chemic heart disease induced a paradoxical result. The
higher was the LDL-C, the lower was the ischemic risk.
Therefore, we studied the biased population of the statin-
untreated and statin-treated groups.
However, many patients with lifestyle diseases, including
diabetes, are treated with statins. It is useful to include
LDL-C data because most outpatients are in the same
situation. We analyzed UA findings in a similar manner.We evaluated statistical multicollinearity. A strong
correlation (correlation coefficient, 0.523; P = 0.00) was
observed between maximum IMT and plaque score. The
correlated data resulted in multicollinearity in multilo-
gistic regression analysis. We discarded the plaque score
and adopted maximum IMT because it had a stronger
correlation with ischemic heart disease.
After conducting unilogistic regression analysis between
ischemic heart disease and each dependent variable, multi-
logistic regression analysis was conducted after controlling
simultaneously for potential cofounders such as ECG find-
ings, aortic calcification, minimum ABI, maximum IMT,
LDL-C, and UA (Table 2). Our results did not have a mul-
ticollinearity problem.
The regression equation (Y) was as follows:
Y ¼ 2:02 ECG changeð Þ þ 1:55 aortic calcificationð Þ
−1:42 minABIð Þ þ 0:147 maxIMTð Þ−0:041
 LDL−Cð Þ þ 0:211 UAð Þ þ 0:147
The receiver operating characteristic (ROC) curve for
ischemic heart disease in the 337 patients with diabetes
derived using the above regression equation is shown in
Figure 1. The area under the curve (AUC) was 0.879
(0.820–0.938, P = 0.00; Figure 1).
The logistic equation calculated the cut-off value to
be −1.84 at the nearest point on the curve from the coord-
inate (0,1). The classification results for a cut-off value
of −1.84 are shown in Table 3. According to this cut-off
Table 2 Results of multivariate logistic regression analysis with ischemic heart disease and each independent variable
Partial regression coefficient Odds ratio Lower 95% CI Upper 95% CI P-value
Minimum value of ABI −1.42 0.242 0.023 2.50 0.23
Aortic calcification in plain chest radiographs 1.55 4.71 1.93 11.5 0.001
ST-T change or abnormal Q in ECG 2.02 7.53 3.17 17.9 <0.001
LDL-C −0.041 0.960 0.943 0.970 <0.001
Maximum IMT 0.147 1.16 0.803 1.67 0.43
Uric acid 0.211 1.24 0.900 1.70 0.19
Intercept 0.147 1.16 0.94
The chi-square value for the omnibus test of model coefficients was 78.29 (P = 0.00). The chi-square value was 5.669 for the Lemeshow and Hosmer test
(P = 0.684). It was denied that the regression equation does not fit.
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were in the high-risk category for the 5 years. Eight of the
264 patients in the low-risk group developed ischemic
heart disease, while 29 of the 73 patients in the high-risk
group suffered ischemic heart disease. Sensitivity was
78.4%, specificity was 85.3%, and the negative predictive
value was 97.0%. Therefore, this cut-off value was ad-
equate for screening the disease for diabetic outpatients.
Discussions
It is extremely difficult to evaluate ischemic heart disease,
which exhibits few symptoms, with simple testing. Gener-
ally, tests to evaluate ischemic heart disease include ECG
at rest, exercise ECG, electrocardiography, dobutamine
stress electrocardiography, a cardiac radioisotope examin-
ation, and cardiac computed tomography. ECG at rest is
safe and inexpensive, but its specificity and sensitivity is
not high, particularly in cases of angina pectoris [18].Figure 1 Receiver operating characteristic curves for predicting
ischemic heart disease from 2008 to 2013 Area under the
curve = 0.879 (0.820–0.938; P = 0.00).Exercise ECG comes second in terms of cost, after ECG
at rest. Although an exercise ECG can help in diagnosing
structural or functional stenosis, mass screening is difficult
because of time constraints. The sensitivity of exercise ECG
is 70% and the specificity is 75%; therefore, it does not re-
sult in sufficient specificity in a mass screening [19-23].
Moreover, the exercise can trigger a ischemic heart disease,
and handicapped patients cannot complete the test [24].
Cardiac ultrasonography shows akinesis of the cardiac
wall in patients with unstable angina and infarction, but
abnormal findings appear during the late stage of the
clinical course. Other tests, including dobutamine stress
ECG, cardiac radioisotope examinations, and cardiac CT
are also useful at the late stage of the disease; however,
these are invasive, pose a radiation risk, or are expensive.
Our study used a screening survey and cardiac expertise
to develop atherosclerotic evidence.
Our results showed a larger AUC for the ROC curve
compared with that in previous studies. Staging of athero-
sclerosis as it progresses is not uniform organ by organ. A
previous study combined the Framingham score and ABI
results or those of cervical artery ultrasonography to show
the progression of atherosclerosis in a local area. In con-
trast, our study unites broad information from every organ,Table 3 Onset prediction of ischemic heart disease using
the logistic regression equation and the number of






Logistic regression equation (+) 29 44 73
Logistic regression equation (−) 8 256 264
Total 37 300 337
The cut-off value in the logistic regression equation (Y) was calculated from the
receiver operating characteristic (ROC) curve. The shortest distance from the
coordinates
(1-specificity, sensitivity) = (0.0, 1.0) was found on the ROC curve in Figure 1. The
value of the logistic regression equation (Y) corresponding to the coordinates was
−1.84. The cut-off value for the logistic regression equation (Y) of −1.84 divided the
outpatients into low-risk and high-risk groups according to the risk of ischemic heart
disease. The outpatients were classified according to the presence or absence of
ischemic heart disease.
※ Y = 2.02 × (ECG change) + 1.55 × (aortic calcification) − 1.42 ×
(min ABI) + 0.147 × (max IMT) − 0.041 × (LDL-C) + 0.211 × (UA) + 0.147.
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nosed by ABI, cervical artery atherosclerosis diagnosed by
ultrasonography, and aortic atherosclerosis diagnosed by
aortic calcification on plain chest radiographs.
An evaluation of the general progression of athero-
sclerosis was accomplished with more accurate scoring
and a larger AUC. We cannot predict ischemic heart
disease in a patient with diabetes using high sensitive
C-reactive protein level, HbA1c level, UA findings, or
LDL-C level. These patients have been at risk of ath-
erosclerosis for some time. An evaluation of athero-
sclerotic risk using blood chemistry is useful for
predicting long-term future attacks.
A question that deserves further elucidation is the po-
tential use of biomarkers of endothelial cell activation that
have been found to be useful predictors of cardiovascular
events in chronic diseases associated with increased risk of
cardiovascular death. It is the case of angiopietin-2 or os-
teoprotegerin that have been found to be good predictors
of cardiovascular disease and subclinical atherosclerosis in
patients with rheumatoid arthritis [25,26].
However, physical and imaging studies, such as elec-
trocardiography, plain chest radiography, and cervical
artery ultrasonography are superior for predicting
short-term future risk. Evaluation of the real-time pro-
gression of atherosclerosis is important for a better pre-
dictive result.
There is a possibility that some variations in data from
the physical tests or imaging studies were caused by hu-
man error. Moreover, the characteristics of an outpatient
population are different in each hospital, and our logistic
equation could not be directly applied for patients at
other hospitals. Nevertheless, the same combination of
tests could be used to extract a high-risk group.
In our study, patients with diabetes who visited our
hospital for 5 years were retrospectively analyzed. the
observation period is long-term and medications such
as hypoglycemic agents, statins, and anti-hyperuricemic
drugs have been treated for observation period. While
some might state that this study was biased compared
to the Framingham study, which targeted members of
the general population, it is impossible to consider that
some diabetes patients already approved for treatment
may not undergo treatment intervention. From the per-
spective of LDL-C level evaluation, the population in-
cluded both patients being administered statins and
patients not being administered statins so this data
could have some bias. However, when patients have
lifestyle-related diseases such as diabetes, statin admin-
istration is usually performed in line with guidelines;
in this sense, we believe that it is realistic to evaluate
biased data. Accordingly, we decided to also use LDL-C
levels as data, regardless of whether patients were being
administered. For the same reason, uric acid and bloodglucose levels were also adopted regardless of whether
patients were being administered antihyperuricemic
drugs, hypoglycemic drugs or insulin.
Thus, blood glucose, lipids and blood pressure were
managed in diabetes patients according to guidelines
and we therefore believe that our prediction model is
more practical than other previously reported models
for predicting onset of ischemic heart disease in dia-
betes patients actually undergoing treatment.
Diabetes is a disease that can cause arteriosclerotic
disease throughout the body and ischemic heart dis-
ease could be more accurately predicted by combining
physiological testing to search multilaterally for ar-
teriosclerotic disease without limiting the search to a
certain area.
Moreover, in rheumatoid arthritis patients, combin-
ing this logistic function and endothelial cell activation
markers such as angiopietin-2 and osteoprotegerin
could increase ischemic heart disease onset prediction
probability.
Conclusions
We speculate that our screening system is useful and in-
expensive compared to the myocardial scintigraphy or
cardiac CT inspection. In addition, if we diagnose a high
risk patient by using our screening system, we can make
an intervention to reduce the risk. Therefore, our
screening method is very useful, less invasive, high effi-
cient, and cost-effective for diabetic cardiovascular risk.
It is very important to score the risk for a stepped-care
approach to prevent the progression of diabetes physic-
ally and mentally.
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